Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
Podcasts
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
Podcasts
About
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 108, Issue 1
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Review
Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases
Online download statistics by month:
Online download statistics by month: May 2021 to April 2022
Abstract
Full
Pdf
May 2021
1811
205
177
Jun 2021
90
57
39
Jul 2021
35
29
21
Aug 2021
13
10
9
Sep 2021
11
7
8
Oct 2021
785
630
152
Nov 2021
824
44
25
Dec 2021
2644
171
148
Jan 2022
625
90
70
Feb 2022
431
35
26
Mar 2022
323
37
28
Apr 2022
349
22
19
Total
7941
1337
722
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via BCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF